Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger April 21, 2026 Read More »
Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses March 27, 2026 Read More »
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan March 26, 2026 Read More »
Ponce Aurora Appoints Former Estee Lauder Executive as Chief Commercial Officer Ahead of Longevity Product Launches February 12, 2026 Read More »
